Optimal DaTQUANT Thresholds for Diagnostic Accuracy of Dementia with Lewy Bodies (DLB) and Parkinson's Disease (PD)

被引:0
作者
Kuo, Phillip H. [1 ,2 ]
Cella, Patrick [3 ]
Chou, Ying-Hui [4 ]
Arkhipenko, Alexander [5 ]
Fisher, Julia M. [6 ]
机构
[1] City Hope Natl Med Ctr, Dept Radiol, Duarte, CA 91010 USA
[2] Univ Arizona, Dept Med Imaging Med & Biomed Engn, Tucson, AZ 85724 USA
[3] GE HealthCare, Life Sci, Imaging R&D, Marlborough, MA 01752 USA
[4] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA
[5] GE HealthCare, Pharmaceut Diagnost, Marlborough, MA 01752 USA
[6] Univ Arizona, BIO5 Inst, Stat Consulting Lab, Tucson, AZ 85719 USA
关键词
DaTQUANT; Parkinson disease; Parkinsonism; dementia with Lewy bodies; quantification; threshold; dopamine transporter; 123I-Ioflupane SPECT (123I-FP-CIT-SPECT); ioflupane; DaTscan; MOVEMENT-DISORDERS; SPECT IMAGES; QUANTIFICATION; PERFORMANCE; PROGRESSION; BINDING; SYSTEM; SCANS;
D O I
10.3390/tomography10100119
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Quantitative thresholds are helpful to define an abnormal DaT SPECT in patients with suspected nigrostriatal degenerative diseases (NSDD). The optimal DaTQUANT threshold for diagnostic accuracy of DaT SPECT across combined movement and cognitive disorder populations has been previously described. Methods: We established optimal DaTQUANT thresholds that enhance the discrimination between dementia with Lewy bodies (DLB) and non-DLB dementia types, as well as between Parkinsonian syndromes (PS) and conditions not characterized by nigrostriatal degeneration (non-PS). Results: Data from a total of 303 patients were used in this retrospective analysis. Posterior putamen of the more affected hemisphere (MAH) was shown to be an accurate single-variable predictor for both DLB and PS and was comparable to the most accurate multi-variable models. Conclusions: Automated quantification with DaTQUANT can accurately aid in the differentiation of DLB from non-DLB dementias and PS from non-PS. Optimal thresholds for assisting a diagnosis of DLB are striatal binding ratio (SBR) <= 0.65, z-score <= -2.36, and a percent deviation <= -0.54 for the posterior putamen of the MAH. Optimal posterior putamen thresholds for assisting a diagnosis of PS are SBR <= 0.92, z-score <= -1.53, and a percent deviation <= -0.33, which are similar to our previously reported posterior putamen threshold values using a blended patient pool from multiple study populations.
引用
收藏
页码:1608 / 1621
页数:14
相关论文
共 37 条
  • [1] Parkinson's disease: current assessment methods and wearable devices for evaluation of movement disorder motor symptoms-a patient and healthcare professional perspective
    AlMahadin, Ghayth
    Lotfi, Ahmad
    Zysk, Eva
    Siena, Francesco Luke
    Mc Carthy, Marie
    Breedon, Philip
    [J]. BMC NEUROLOGY, 2020, 20 (01)
  • [2] Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis
    Bega, Danny
    Kuo, Phillip H.
    Chalkidou, Anastasia
    Grzeda, Mariusz T.
    Macmillan, Thomas
    Brand, Christine
    Sheikh, Zulfiqar H.
    Antonini, Angelo
    [J]. NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [3] Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia
    Booij, Jan
    Dubroff, Jacob
    Pryma, Daniel
    Yu, Jian
    Agarwal, Rajan
    Lakhani, Paras
    Kuo, Phillip H.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (11) : 1821 - 1826
  • [4] DaTQUANT: The Future of Diagnosing Parkinson Disease
    Brogley, Jacquelyn E.
    [J]. JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2019, 47 (01) : 21 - 26
  • [5] Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years
    Chouker, M
    Tatsch, K
    Linke, R
    Pogarell, O
    Hahn, K
    Schwarz, J
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (06) : 721 - 725
  • [6] Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias
    Colloby, Sean J.
    McParland, Shane
    O'Brien, John T.
    Attems, Johannes
    [J]. BRAIN, 2012, 135 : 2798 - 2808
  • [7] Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group
    D'Antonio, Fabrizia
    Kane, Joseph P. M.
    Ibanez, Agustin
    Lewis, Simon J. G.
    Camicioli, Richard
    Wang, Huali
    Yu, Yueyi
    Zhang, Jing
    Ji, Yong
    Borda, Miguel German
    Kandadai, Rukmini Mridula
    Babiloni, Claudio
    Bonanni, Laura
    Ikeda, Manabu
    Boeve, Bradley F.
    Leverenz, James B.
    Aarsland, Dag
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [8] GE, HealthCare DATSCAN (Ioflupane I 123 Injection) Prescribing Information
  • [9] Jennings D, 2014, NEUROLOGY, V83, P1739, DOI 10.1212/WNL.0000000000000960
  • [10] Jiang WY, 2008, STAT APPL GENET MOL, V7